HBV Citations List: August 2023

Literature Citations

1. Identification of Novel Tetrahydroquinoxaline Derived Phenyl Ureas as Modulators. Hwang N, Wu S, Ban H, Luo H, Ma J, Cheng J, Zhao Q, Laney JA, Du N, Guo J, Suresh M, Shen L, Tolufashe G, Viswanathan U, Kulp J, Lam P, Chang J, Clement JA, Menne S, Guo JT, Du Y. European Journal of Medicinal Chemistry, 2023. 259: 115634. PMID[37499290].
[PubMed]. HBV_08_2023.

2. Novel anti‑Hepatitis B Virus Flavonoids Sakuranetin and Velutin from Rhus retinorrhoea. Ahmed S, Parvez MK, Al-Dosari MS, Abdelwahid MAS, Alhowiriny TA, Al-Rehaily AJ. Molecular Medicine, 2023. 28(3): 176. PMID[37539729].
[PubMed]. HBV_08_2023.

3. Synthesis of IR-415 Derivatives and Evaluation of Their Antiviral Activity against Hepatitis B Virus. Singh, A., J. Kumar, J. Verma, N. Subbarao, S. Sapra, A.K. Prasad, V. Kumar, and D. Sharma. ChemistrySelect, 2023. 8(29): e202300701. ISI[001040567400001].
[WOS]. HBV_08_2023.

4. Preclinical Characterization of a Novel Liver-focused Small Molecule Efficiently Inhibiting Hepatitis B Virus by Activating Type I Interferon Signaling. Tang, A., L.D. Guo, X. Xu, N. Unchwaniwala, L. Li, C. Li, M. Shen, J.X. Yu, H. Pajouhesh, M.P. Windisch, M. Perron, M.A. Walker, W. Delaney, M. Zhong, and K. Zhang. Hepatology, 2023. 77(5): p. E159-E159. ISI[001034828200052].
[WOS]. HBV_08_2023.

Patent Citations

This month, no relevant HBV patents were identified.